Comparison guide
Alpha-lipoic acid or R-ALA?
Standard alpha-lipoic acid is a racemic mix of two isomers; R-ALA is the naturally occurring, biologically active one and reaches higher blood levels. The catch is that nearly all the neuropathy evidence used racemic ALA at 600 mg/day, and no trial has compared the two on symptoms.
The options, compared
| Option | Evidence | Best for | The honest note | |
|---|---|---|---|---|
| Alpha-Lipoic Acid | Moderate evidence | Diabetic neuropathy symptoms | At 600 mg/day on an empty stomach it reduced neuropathy symptom scores in the SYDNEY 2 trial; higher doses added side effects, not benefit. It is not a weight-loss agent — the pooled effect was 0.69 kg. | View |
| R-Alpha Lipoic Acid | Moderate evidence | Better absorption, unproven payoff | Reached higher plasma levels than racemic ALA in a pilot study, and products are dosed at 100–300 mg/day on that basis. Whether that gives any better clinical result is untested. | View |
Our verdict
Take standard racemic alpha-lipoic acid at 600 mg/day if you want the form and dose the neuropathy trials actually used. R-ALA is a reasonable choice only if you accept paying more for an absorption edge without clinical proof. Skip both for weight loss, and monitor your blood glucose if you use insulin or a sulfonylurea.